Related Experiment Videos
Lipoxygenase in Human Tumor Cells
1Deutsches Krebsforschungszentrum, Division of Tumor Biochemistry, Heidelberg, Germany.
Pathology Oncology Research : POR
|January 1, 1997
Summary
12-lipoxygenase and its metabolite 12(S)-HETE promote tumor metastasis. Targeting 12-lipoxygenase expression in tumor cells offers a potential therapeutic strategy for cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Tumor cell proliferation and metastasis involve complex molecular signaling pathways.
- Arachidonate metabolites, produced via cyclooxygenase and lipoxygenase enzymes, play a role in carcinogenesis.
- 12-lipoxygenase is a key enzyme in arachidonate metabolism, generating prometastatic mediator 12(S)-HETE.
Purpose of the Study:
- To review the role of 12-lipoxygenase in human tumor cells.
- To investigate the mechanisms of 12-lipoxygenase activation and expression modulation.
- To highlight the therapeutic potential of targeting 12-lipoxygenase in cancer treatment.
Main Methods:
- Literature review focusing on 12-lipoxygenase and its role in cancer.
- Analysis of molecular mechanisms underlying 12-lipoxygenase expression and activity.
- Evaluation of in vitro and in vivo studies on 12(S)-HETE effects.
Main Results:
- 12(S)-HETE, a metabolite of 12-lipoxygenase, exhibits prometastatic effects on tumor cells.
- Human tumor cells express 12-lipoxygenase or respond to its metabolites.
- Mechanisms of 12-lipoxygenase activation and expression modulation are crucial.
Conclusions:
- 12-lipoxygenase is a significant contributor to tumor cell metastasis.
- Targeting 12-lipoxygenase expression presents a promising therapeutic avenue for cancer.
- Understanding 12-lipoxygenase pathways can lead to novel anti-cancer strategies.